Lisa Aaron
Overview
Explore the profile of Lisa Aaron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta A, Singh P, Aaron L, Montepiedra G, Chipato T, Stranix-Chibanda L, et al.
Lancet Child Adolesc Health
. 2023 Aug;
7(10):708-717.
PMID: 37634517
Background: Infants born to women with HIV in settings with a high tuberculosis burden are at risk of tuberculosis infection and rapid progression to active disease. Maternal isoniazid preventive therapy...
2.
Mandima P, Baltrusaitis K, Montepiedra G, Aaron L, Mathad J, Onyango-Makumbi C, et al.
BMC Pregnancy Childbirth
. 2023 Jan;
23(1):34.
PMID: 36650479
Background: This exploratory analysis investigates the prevalence and risk factors of neurocognitive toxicity in postpartum women on HIV treatment in response to a concern of an Isoniazid Preventive Therapy (IPT)/Efavirenz...
3.
Kirmse B, Hobbs C, Aaron L, Montepiedra G, Summar M, Williams P, et al.
Pediatr Infect Dis J
. 2022 May;
41(8):e306-e311.
PMID: 35622436
Background: Mitochondrial toxicity resulting in myopathy and lactic acidosis has been described in antiretroviral (ARV)-exposed patients. We hypothesized that myopathy in HIV-infected, ARV-treated children would be associated with metabolic (acylcarnitines)...
4.
Tamandjou Tchuem C, Cotton M, Nel E, Tedder R, Preiser W, Violari A, et al.
BMC Pediatr
. 2020 Dec;
20(1):563.
PMID: 33357228
Background: Whilst much attention is given to eliminating HIV mother-to-child transmission (MTCT), little has been done to ensure the same for hepatitis B virus (HBV) transmission. The introduction of HBV...
5.
Theron G, Montepiedra G, Aaron L, McCarthy K, Chakhtoura N, Jean-Philippe P, et al.
Clin Infect Dis
. 2020 Sep;
72(11):e784-e790.
PMID: 32997744
Background: International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1078, a randomized noninferiority study designed to compare the safety of starting isoniazid preventive therapy (IPT) in women living with human...
6.
Gausi K, Wiesner L, Norman J, Wallis C, Onyango-Makumbi C, Chipato T, et al.
Clin Pharmacol Ther
. 2020 Sep;
109(4):1034-1044.
PMID: 32909316
The World Health Organization guidelines recommend that individuals living with HIV receive ≥ 6 months of isoniazid preventive therapy, including pregnant women. Yet, plasma isoniazid exposure during pregnancy, in the...
7.
Weinberg A, Aaron L, Montepiedra G, Sterling T, Browning R, Mmbaga B, et al.
Clin Infect Dis
. 2020 Jul;
73(9):e3555-e3562.
PMID: 32720695
Background: Pregnancy is accompanied by immune suppression. We hypothesized that Mycobacterium tuberculosis-specific inflammatory responses used to identify latent tuberculosis infection (LTBI) lose positivity during pregnancy. We also hypothesized that isoniazid...
8.
Gupta A, Montepiedra G, Aaron L, Theron G, McCarthy K, Bradford S, et al.
N Engl J Med
. 2019 Oct;
381(14):1333-1346.
PMID: 31577875
Background: The safety, efficacy, and appropriate timing of isoniazid therapy to prevent tuberculosis in pregnant women with human immunodeficiency virus (HIV) infection who are receiving antiretroviral therapy are unknown. Methods:...
9.
Melvin A, Montepiedra G, Aaron L, Meyer 3rd W, Spiegel H, Borkowsky W, et al.
Pediatr Infect Dis J
. 2016 Oct;
36(1):53-60.
PMID: 27749649
Background: Human immunodeficiency virus (HIV)-infected children receiving antiretroviral therapy (ART) have increased prevalence of hyperlipidemia and risk factors for cardiovascular disease. No studies have investigated the efficacy and safety of...
10.
Sirois P, Aaron L, Montepiedra G, Pearson D, Kapetanovic S, Williams P, et al.
Pediatr Infect Dis J
. 2016 Jan;
35(1):e12-8.
PMID: 26741589
Background: Limited empirical investigation exists into longitudinal changes in cognition, behavior or quality of life (QOL) in children with perinatal HIV who are prescribed stimulants. Methods: This study was an...